About CBD
The Centre for Biomedical Devices (CBD) focusses on the research, fabrication, licensing, and production of medical devices. CBD covers the full spectrum from concept to technology transfer, including design, computer-aided modelling, in-silico evaluation, fabrication, prototyping, and functional evaluation.
CBD has six divisions—four dedicated to medical device development and two supporting precision fabrication of prototypes and animal models for pre-clinical evaluation.
Primary Divisions of CBD
Division of Artificial Organs and Associated Technology.
Driven by innovative boldness, this division excels in design, prototyping, in vitro evaluation, process development, and technology documentation. It offers expertise in the design, drawing, and polishing of medical device components, and automated instrumentation development. The division includes a Modelling & Prototyping Laboratory and a Devices Testing Laboratory. Genomics and auto-engineering of tissues will also be a part of this division.
Division of Extra or Paracorporeal Devices
This division designs and develops medical devices for clinical use, transferring technology to industry for commercial production applications, and collaborating with industrial partners to set up manufacturing facilities. Current projects include left ventricular assist devices, total artificial heart, ECMO, donor organ support devices, artificial pacemakers, implantable pulse generators, and dialyzers.
Additionally, the division focuses on energy-based technologies like atmospheric pressure plasma therapy devices, transcutaneous energy transfer systems (TETS), and BSRM motors. It also supports rapid prototyping for ongoing product development at GIMSR or GITAM (Deemed to be University).
Division of In Vivo Models and Testing
This division houses CPCSEA-registered large animals and breeds large experimental animals, providing round-the-clock veterinary care. It specialises in the animal evaluation of devices like heart valves, vascular grafts, blood oxygenators, coronary stents, ureteric stents, CVP catheters, PDA closure devices, bone substitutes, dental materials, biological materials, and transcutaneous valves, etc.
Additionally, it develops animal models for various pathological states to study and evaluate new treatment methods.